{"organizations": [], "uuid": "4c6c8d7000e201f9cea5034581b45b41b0d8210c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-spark-therapeutics-enters-into-a-s/brief-spark-therapeutics-enters-into-a-spk-9001-manufacture-and-supply-agreement-with-pfizer-idUSFWN1QA0KA", "country": "US", "domain_rank": 408, "title": "BRIEF-Spark Therapeutics Enters Into A Spk-9001 Manufacture And Supply Agreement With Pfizer", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-20T21:23:00.000+02:00", "replies_count": 0, "uuid": "4c6c8d7000e201f9cea5034581b45b41b0d8210c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-spark-therapeutics-enters-into-a-s/brief-spark-therapeutics-enters-into-a-spk-9001-manufacture-and-supply-agreement-with-pfizer-idUSFWN1QA0KA", "ord_in_thread": 0, "title": "BRIEF-Spark Therapeutics Enters Into A Spk-9001 Manufacture And Supply Agreement With Pfizer", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Spark Therapeutics Inc:\n* SPARK THERAPEUTICS INC - ON FEB 16, CO ENTERED INTO A SPK-9001 MANUFACTURE AND SUPPLY AGREEMENT WITH PFIZER - SEC FILING\n* SPARK THERAPEUTICS SAYS UNDER AGREEMENT, PFIZER WILL PAY CO $7 MILLION UPON EXECUTION OF AGREEMENT - SEC FILING\n* SPARK THERAPEUTICS INC - THE AGREEMENT IS TO MANUFACTURE AND DELIVER TO PFIZER SPARK-9001 BULK DRUG SUBSTANCE\n* SPARK THERAPEUTICS INC - UNDER AGREEMENT, PFIZER MAY MAKE A SECOND PAYMENT TO CO OF UP TO $7 MILLION\n* SPARK THERAPEUTICS INC - CO WILL BEGIN SPARK-9001 BULK DRUG SUBSTANCE MANUFACTURE IN THE FIRST QUARTER OF 2018 Source text for Eikon: ( bit.ly/2sFvnr8 ) Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2sFvnr8"], "published": "2018-02-20T21:23:00.000+02:00", "crawled": "2018-02-21T21:23:50.006+02:00", "highlightTitle": ""}